Business Context and Reporting Period
Company: Brooks Automation, Inc. (Note: Input metadata referenced "Azenta, Inc.", but the filing text is for Brooks Automation, Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2011
Business Overview: A leading provider of automation, vacuum, and instrumentation solutions, primarily serving the semiconductor manufacturing industry (approx. 81% of revenue for the first half of fiscal 2011). The company operates through three segments: Critical Solutions Group, Systems Solutions Group, and Global Customer Operations.
Key Financial Metrics
| Metric | Three Months Ended Mar 31, 2011 | Six Months Ended Mar 31, 2011 |
|---|---|---|
| Total Revenues | $192.7 million | $371.0 million |
| Gross Profit | $61.7 million (32.0% margin) | $119.0 million (32.1% margin) |
| Operating Income | $26.7 million | $50.5 million |
| Net Income (Attributable to Brooks) | $26.6 million | $50.1 million |
| Diluted EPS | $0.41 | $0.77 |
| Cash & Cash Equivalents | $59.3 million (as of Mar 31, 2011) | |
| Total Marketable Securities | $115.4 million (Short-term: $59.5M; Long-term: $55.8M) | |
| Net Cash Provided by Operating Activities | $38.9 million (Six months) |
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 29.9% year-over-year for the quarter and 45.8% for the six-month period, driven by increased volume shipments in response to rising demand for semiconductor capital equipment.
- Margin Expansion: Gross margin percentage improved to 32.0% (Q1 2011) from 26.3% (Q1 2010), primarily due to higher absorption of indirect factory overhead on increased revenues.
- Profitability: Net income attributable to Brooks Automation increased 26.5% for the quarter and 174.6% for the six-month period compared to the prior year.
- One-Time Items: The prior year period (Q1 2010) included a $7.8 million gain from the sale of intellectual property rights, which was not present in the current period. Conversely, the current period benefited from reduced charges related to excess and obsolete inventory compared to the prior year.
Outlook, Risks, and Unusual Items
- Asset Sale (Subsequent Event): On April 20, 2011, the company agreed to sell its extended factory contract manufacturing business to affiliates of Celestica Inc. for approximately $78 million in cash. The company expects to record a gain of $42 million to $46 million upon closing (expected Q3 FY2011).
- Acquisition (Subsequent Event): On April 1, 2011, the company acquired RTS Life Sciences for approximately $3.3 million (net of cash).
- Legal Settlement: A settlement regarding past stock option granting practices (Therrien litigation) was executed in February 2011. Upon court approval, the company expects to record approximately $4 million in income.
- Risk Factors: The company highlighted risks related to disruptions in the supply of components from Japan due to natural disasters, which could impact manufacturing and shipments. Additionally, the business remains subject to the cyclical nature of the semiconductor industry.
- Guidance: Management noted plans to use cash from the asset sale to leverage technology capabilities in non-semiconductor market sectors. No specific numerical guidance for future quarters was provided in this text.
Investor Verification Checklist
- Asset Sale Closing: Verify the final closing date and purchase price adjustments for the Celestica asset sale to confirm the expected $42M-$46M gain.
- Legal Settlement Approval: Confirm court approval of the Therrien litigation settlement to realize the expected $4 million income.
- Supply Chain Impact: Monitor the duration and severity of supply chain disruptions from Japanese suppliers following the natural disasters.
- Segment Mix: Review the impact of the divestiture on future revenue mix, as the Extended Factory business (part of Systems Solutions) is being sold.
- Tax Position: Note the company maintains a full valuation allowance on net deferred tax assets, meaning future tax benefits from NOLs may not be realized.